Scotts Miracle-Gro Q1 2020 Earnings Beat Estimates – The Way to Play Marijuana Legalization Scott Willis·January 29, 2020ScottsMiracle-Gro (NYSE: SMG) is a multi-year play on the rapid growth of the marijuana industry. Did this quarter's...Investing·0 Comments·
Apple Posts Q1 2020 Earnings Double Beat – The Next Big Software Behemoth? Andy Zhou·January 28, 2020As Apple (NASDAQ: AAPL) transitions into a software company, this quarter revenue was $91.8B and EPS of $4.99,...Investing·0 Comments·
EBay Q4 Earnings Delight but Growth Remains a Problem for This Stock Scott Willis·January 28, 2020EBay beat on Q4 earnings but is struggling to find growth. Is the juicy 18% buyback yield sustainable?Investing·0 Comments·
AMD Q4 2019 Earnings Meet Sky High Expectations Don Weaver·January 28, 2020AMD (NASDAQ: AMD) reported Q4 2019 earnings meeting estimates on both the top and bottom lines, but slowing sales growth in 2020 is a cause for concern.Investing·0 Comments·
Starbucks Beats Q1 Earnings Estimates as Coronavirus Concerns Loom Scott Willis·January 28, 2020Starbucks (NASDAQ: SBUX) beat first quarter earnings expectations. The impact of the coronavirus on the key China market...Investing·0 Comments·
CN Rail Q4 Results Delight – Economic Growth Still a Headwind Scott Willis·January 28, 2020CN managed to beat results even with economic growth headwinds. The underperformance against peers could be over.Investing·0 Comments·
SAP Earnings Show Competitive Headwinds Are Brewing Don Weaver·January 28, 2020SAP (NYSE: SAP) earnings missed revenue expectations but beat estimates on bottom line earnings. However, 2020 guidance for...Investing·0 Comments·
Lockheed Martin Q4 2019 Earnings Double Beat – Stock at All-Time High Amid Rising Global Tensions Andy Zhou·January 28, 2020Lockheed Martin (NYSE: LMT) Q4 2019 earnings: Revenue was $15.87B beating analysts' estimates of $15.28B. EPS was at...Investing·0 Comments·
Pfizer Misses Q4 Earnings Estimates – Is the Stock’s 5-Month Rally Alive and Well? Andrew·January 28, 2020Pfizer (NYSE: PFE) missed 2019 Q4 earnings estimates. Investors will be focused on comments around the New Pfizer...Investing·0 Comments·
